CENTOCOR, INC.
🇺🇸United States
A Study of the Safety and Effectiveness of Infliximab for the Treatment of Psoriatic Arthritis
Phase 3
Completed
- Conditions
- First Posted Date
- 2003-01-15
- Last Posted Date
- 2011-05-17
- Lead Sponsor
- Centocor, Inc.
- Target Recruit Count
- 70
- Registration Number
- NCT00051623
A Study of Abciximab and Reteplase When Administered Prior to Catherization After a Myocardial Infarction (Finesse)
- First Posted Date
- 2002-09-25
- Last Posted Date
- 2014-07-31
- Lead Sponsor
- Centocor, Inc.
- Target Recruit Count
- 2461
- Registration Number
- NCT00046228
A Safety and Efficacy Study for Infliximab (Remicade) in Patients With Active Ulcerative Colitis
Phase 3
Completed
- Conditions
- First Posted Date
- 2002-05-13
- Last Posted Date
- 2011-05-17
- Lead Sponsor
- Centocor, Inc.
- Target Recruit Count
- 364
- Registration Number
- NCT00036439
A Study of the Safety and Effectiveness of Infliximab (Remicade) in Patients With Rheumatoid Arthritis.
Phase 3
Completed
- Conditions
- First Posted Date
- 2002-05-10
- Last Posted Date
- 2011-05-19
- Lead Sponsor
- Centocor, Inc.
- Target Recruit Count
- 347
- Registration Number
- NCT00036387
A Study of the Safety and Effectiveness of Infliximab (Remicade) in Patients With Juvenile Rheumatoid Arthritis
Phase 3
Completed
- Conditions
- First Posted Date
- 2002-05-10
- Last Posted Date
- 2011-05-17
- Lead Sponsor
- Centocor, Inc.
- Target Recruit Count
- 123
- Registration Number
- NCT00036374
© Copyright 2024. All Rights Reserved by MedPath